Your browser doesn't support javascript.
loading
Plasma amyloid-ß levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden.
Rembach, Alan; Watt, Andrew D; Wilson, William J; Villemagne, Victor L; Burnham, Samantha C; Ellis, Kathryn A; Maruff, Paul; Ames, David; Rowe, Christopher C; Macaulay, S Lance; Bush, Ashley I; Martins, Ralph N; Masters, Colin L; Doecke, James D.
Afiliação
  • Rembach A; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, VIC, Australia.
  • Watt AD; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, VIC, Australia.
  • Wilson WJ; CSIRO Mathematics, Informatics & Statistics, North Ryde, NSW, Australia.
  • Villemagne VL; Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, VIC, Australia.
  • Burnham SC; CSIRO Preventative Health Flagship: Mathematics, Informatics and Statistics, Perth, WA, Australia.
  • Ellis KA; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, VIC, Australia Department of Psychiatry, St. George's Hospital, University of Melbourne, VIC, Australia National Ageing Research Institute, Parkville, VIC, Australia.
  • Maruff P; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, VIC, Australia CogState Ltd., Melbourne, VIC, Australia.
  • Ames D; National Ageing Research Institute, Parkville, VIC, Australia.
  • Rowe CC; Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, VIC, Australia.
  • Macaulay SL; CSIRO Molecular and Health Technologies, Preventative Health Flagship, Parkville, VIC, Australia.
  • Bush AI; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, VIC, Australia.
  • Martins RN; Sir James McCusker Alzheimer's Disease Research Unit (Hollywood Private Hospital), Perth, WA, Australia.
  • Masters CL; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, VIC, Australia.
  • Doecke JD; CSIRO Mathematics, Informatics & Statistics, North Ryde, NSW, Australia CSIRO Molecular and Health Technologies, Preventative Health Flagship, Parkville, VIC, Australia The Australian E-Health Research Centre, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
J Alzheimers Dis ; 40(1): 95-104, 2014.
Article em En | MEDLINE | ID: mdl-24334723
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Peptídeos beta-Amiloides / Transtornos Cognitivos / Neocórtex / Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Alzheimers Dis Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Peptídeos beta-Amiloides / Transtornos Cognitivos / Neocórtex / Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Alzheimers Dis Ano de publicação: 2014 Tipo de documento: Article